Challenges facing HIV-positive persons who use drugs and their families in Vietnam

Abstract

It is hypothesized that persons who use drugs (PWUD) in Vietnam who are also HIV-positive may face additional challenges in psychosocial outcomes, and these challenges may extend to their family members. In this study, we examined depressive symptoms, stigma, social support, and caregiver burden of HIV-positive PWUD and their family members, compared to the outcomes of HIV-negative PWUD and their family members. Baseline, 3-month, and 6-month assessment data were gathered from 83 PWUD and 83 family members recruited from four communes in Phú Thọ Province, Vietnam. For PWUD, although we observed a general decline in overall stigma over time for both groups, HIV-positive PWUD consistently reported significantly higher overall stigma for all three periods. Depressive symptoms among family members in both groups declined over time; however, family members of HIV-positive PWUD reported higher depressive symptoms across all three periods. In addition, family members of HIV-positive PWUD reported lower levels of tangible support across all three periods. Caregiver burden among family members of HIV-positive PWUD increased significantly over time, whereas the reported burden among family members of HIV-negative PWUD remained relatively unchanged. The findings highlight the need for future interventions for PWUD and family members, with targeted and culturally specific strategies to focus on the importance of addressing additional stigma experienced by PWUD who are HIV-positive. Such challenges may have direct negative impact on their family members' depressive symptoms, tangible support, and caregiver burden.

Keywords:

• persons who use drugs
• family members
• HIV-positive drug users
• Vietnam

Acknowledgments

The content is solely the responsibility of the authors and does not necessarily represent the views of the NIH. We would like to thank the project team members in Hanoi and Phú Thọ Province, Vietnam, for their contributions to this study.

Additional information

Funding

This study was funded by National Institute on Drug Abuse (NIDA/NIH) [grant number R34DA029493]. Dr Lee's time for this study was supported by the National Institute of Mental Health (NIMH) [grant number 5K01MH085503].